Pharmaceutical Interventions
-
4.0KMechanism of Action of Atropine in Controlling Myopia Progression
October 1, 2020 By Huy Tran, MD, and Thao Ha, MD Myopia is the most common refractive error worldwide and is estimated...
-
6.0KTopical Low-Dose Atropine: A Global Perspective
June 24, 2020 By Dwight Akerman, OD, MBA, FAAO, FBCLA Chief Medical Editor, Review of Myopia Management The use of atropine to...
-
3.3KEyenovia Developing a Microdose Treatment for Delivering Atropine
June 12, 2020 The clinical-stage ophthalmic biopharmaceutical company Eyenovia is developing a microdose treatment that is designed to improve the delivery of...
-
5.3KOne Drop into Each Eye at Bedtime: What Could be Simpler?
May 1, 2020 By Laura Kirkeby, CO The use of atropine has been known to slow the progression of myopia for many...
-
1.7KWhat is the Optimal Concentration of Topical Low-dose Atropine?
April 1, 2020 By Dwight Akerman, OD, MBA, FAAO Chief Medical Editor, Review of Myopia Management Topical low-dose atropine is an...
-
6.2KRecommendations for Tapering Long-term Use of Topical Low-dose Atropine
There are two strategies to consider for stopping atropine treatment.
-
3.2KCochrane Systematic Review of Myopia Interventions
March 1, 2020 By Dwight Akerman, OD, MBA, FAAO Chief Medical Editor, Review of Myopia Management To assess the effects of interventions...
-
8.8KCombination Strategies – What is Their Role in Myopia Management?
Individual interventions may not result in the expected efficacy.
-
Interventions for Controlling Myopia Onset and Progression Report
This summary of an International Myopia Institute (IMI) white paper was created by and is used with permission from the Centre for...
-
1.8KWhat’s New with Pharmaceutical Interventions for Myopia
Presently, only atropine, pirenzepine, and 7-methylxanthine are shown to reduce myopia progression in human trials.
-
5.2KEfficacy and Safety of 0.01% Atropine in Myopic Children With European Ancestry
The researchers concluded that topical low-dose atropine appears to be safe and effective in a cohort of European schoolchildren.
-
2.8K
Low-Concentration Atropine for Myopia Progression (LAMP)
A summary of the LAMP Study results
-
1.9K
Orthokeratology, low-dose atropine and axial elongation
Axial elongation rate is faster in younger children undergoing ortho-k treatment.
-
5.5K
Topical Atropine for Myopia Management: The Latest Research
When should one start atropine treatment for myopes?
